quilostigmine has been researched along with Acute Confusional Senile Dementia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cutler, NR; Hourani, J; Jhee, SS; Sramek, JJ | 1 |
| Björk, E; Dahlin, M | 1 |
1 trial(s) available for quilostigmine and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
NXX-066 in patients with Alzheimer's disease: a bridging study.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Indoles; Isoquinolines; Male; Middle Aged | 1999 |
1 other study(ies) available for quilostigmine and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
Nasal administration of a physostigmine analogue (NXX-066) for Alzheimer's disease to rats.
Topics: Administration, Intranasal; Alzheimer Disease; Animals; Area Under Curve; Blood-Brain Barrier; Cholinesterase Inhibitors; Indoles; Isoquinolines; Male; Rats; Rats, Sprague-Dawley | 2001 |